Job title: Senior Manager, DS/DP Development & Manufacturing
Daniel is a Senior Development Engineer in the Conjugation Development Group at ImmunoGen. He serves as the technical lead for all late-stage conjugation development activities. His primary focus has been the process characterization and validation activities surrounding ImmunoGen’s lead product candidate mirvetuximab soravtansine and pipeline candidate IMGN632. In addition, he has been involved in implementing and developing novel continuous conjugation techniques for continuous ADC manufacturing. Prior to joining ImmunoGen, Daniel received his PhD in chemical engineering from Northeastern University.